In June and December of 2024, several 503B registered facilities that have never been inspected by the FDA filed biannual reports listing their compounded products: Bennett Pharmaceuticals of America, LLC: June and December 2024 filings (see appendices) reported that the company created tetracaine hydrochloride, bupivacaine hydrochloride, and phenylephrine hydrochloride in spray bottles, jars, and glass bottleslikely for topical dental anesthetic
Not for human consumption, medical use, or therapeutic application
RESEARCH USE ONLY NOT FOR HUMAN CONSUMPTION.
Its early data is remarkable, with up to 24% weight loss at 36 weeks subcutaneously and 13.1% at 12 weeks orally
The highest dose semaglutide approved for weight loss is 2.4 mg weekly
Type 2 Diabetes Support L-Carnitine may help improve insulin sensitivity and glucose metabolism, although more human trials are needed